Sold as Chloroptic, Chloromycetin. Every FDA application for this active ingredient: 6 branded and 12 generic.
As of Nov 15, 2026, FDA lists 18 applications for Chloramphenicol (sold as Chloroptic, Chloromycetin), first approved Jun 1, 1951, with 0 new uses approved and 0 published complete response letters.
| Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in ChildrenFungal Infection by Site, Tinea Capitis · Sohag University | — | Not yet recruiting | Sep 3, 2026 |
| Clinical, Dermoscopic, and Mycological Evaluations of Resistant DermatophytosisFungal Skin Infection, Tinea Corporis · Sohag University | — | Not yet recruiting | Sep 1, 2026 |
| Chloramphenicol, Tetracycline, Zinc Oxide and Eugenol Paste (CTZ Paste) for Emergency Dental Treatment in Public Health Settings: A Randomized TrialPulp Disease, Dental, Pulp Necrosis · University of Sao Paulo | Early phase 1 | Not yet recruiting | Apr 21, 2026 |
| Lesion Sterilization and Tissue Repair Antibiotic Paste Versus Zinc Oxide and Eugenol Pulpectomy for Treatment of Primary Molars With Pulp NecrosisPulp Necrosis · University of Faisalabad | Phase 1 / Phase 2 | Not yet recruiting | Mar 16, 2026 |
| Jun 1, 1951 | ChloromycetinNDA 50143 | Parkedale | 14 | Discontinued |
| Jun 1, 1951 | ChloromycetinNDA 50156 | Parkedale | 39 | Discontinued |
| Mar 30, 1953 | ChloromycetinNDA 50205 | Parkedale | 27 | Discontinued |
| Jun 20, 1967 | MychelANDA 60851 | Armenpharm | 0 | Discontinued |
| Mar 20, 1968 | ChloropticNDA 50091 | Allergan | 38 | Discontinued |
| Oct 1, 1968 | ChloramphenicolANDA 60133 | Altana | 0 | Discontinued |
| Jul 21, 1970 | Chloroptic S.O.P.ANDA 61187 | Allergan | 10 | Discontinued |
| Nov 18, 1970 | OphthochlorANDA 61220 | Parkedale | 1 | Discontinued |
| Apr 26, 1973 | EconochlorANDA 61645 | Alcon | 0 | Discontinued |
| May 14, 1974 | EconochlorANDA 61648 | Alcon | 2 | Discontinued |
| Apr 28, 1980 | ChloramphenicolANDA 62247 | Ivax Sub Teva Pharms | 4 | Discontinued |
| Aug 31, 1981 | ChloramphenicolANDA 62042 | Epic Pharma LLC | 1 | Discontinued |
| Mar 31, 1982 | OptomycinANDA 62171 | Optopics | 0 | Discontinued |
| Sep 25, 1985 | ChloramphenicolANDA 62628 | Alcon | 10 | Discontinued |
| — | ChlorofairANDA 62437 | Pharmafair | 0 | Discontinued |
| — | ChlorofairANDA 62439 | Pharmafair | 0 | Discontinued |
| — | ChloromycetinNDA 50153 | Parke Davis | 0 | Discontinued |
| — | ChloromycetinNDA 50183 | Parke Davis | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA